Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain

Pharmacogenetics

Volumn 11, Issue 3, 2001, Pages 237-245

  Siegle, I ^a   Fritz, P ^a   Eckhardt, K ^a   Zanger, U M ^a   Eichelbaum, M ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

Cytochrome P4502D6; Human central nervous system; Immunohistochemistry; In situ hybridization

Indexed keywords

CYTOCHROME P450 2D6; MESSENGER RNA; NEUROTOXIN; OPIATE DERIVATIVE; PSYCHOTROPIC AGENT;

ANIMAL CELL; ARTICLE; BRAIN; CAUDATE NUCLEUS; CELLULAR DISTRIBUTION; CEREBELLUM; DRUG TRANSFORMATION; GLIA CELL; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PURKINJE CELL; PUTAMEN; PYRAMIDAL NERVE CELL; RNA ANALYSIS; SUBSTANTIA NIGRA; THALAMUS; TISSUE DISTRIBUTION;

ADULT; ANIMALS; BRAIN; COS CELLS; CYTOCHROME P-450 CYP2D6; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA PROBES; RNA, MESSENGER; TRANSFECTION;

EID: 0035049437     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200104000-00007     Document Type: Article

References (52)

1. Association between the oxidative polymorphism and early onset of Parkinson's disease
2. Cytochrome P450 4A and 2E1 expression in human kidney microsomes
3. Mutant debrisoquine hydroxylation genes in Parkinson's disease
4. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord
5. Metabolic drug inter-actions with selective serotonin reuptake inhibitor (SSRI) antidepressants
6. Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine
7. Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities
8. Neurogenetic correlates of Parkinson's disease: Apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism
9. Differences in interactions of SSRIs
10. 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4-implications for susceptibility to Parkinson's disease
11. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation
12. Functional properties of CYP2D6 1 (wild-type) and CYP2D6 7 (His324-Pro) expressed by recombinant baculovirus in insect cells
13. MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation
14. Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism
15. Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization
16. The human CYP2D locus associated with a common genetic defect in drug oxidation: A G1934-A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3′ splice recognition site
17. Pharmacokinetics of selective serotonin reuptake inhibitors
18. Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR
19. Dopamine formation from tyramine by CYP2D6
20. Antidepressant binding sites in brain: Autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter
21. The use of antiavidin antibody and avidin-biotin complex in immunoperoxidase technics
22. Tryptamine may couple dopaminergic and serotonergic transmission in the brain
23. Debrisoquine/sparteine monooxygenase and other P-450s in brain
24. Genomic cloning and protein expression of a novel rat brain cytochrome P-450 CYP2D18* catalyzing imipramine N-demethylation
25. The human debrisoquine 4-hydroxylase (CYP2D) locus: Sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene
26. 'It's the genes, stupid'. Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism
27. Tryptamine: A possible endogenous substrate for CYP2D6
28. The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: A case-control study and metaanalysis
29. Cytochrome P450 in normal human brain and brain tumours
30. Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain
31. Antidepressants and drug-metabolizing enzymes - Expert group report
32. An autoradiographic study of dextromethorphan high-affinity binding slates in rat brain: Sodium-dependency and colocalization with paroxetine
33. Regional distribution of cytochrome P450 2D1 in the rat central nervous system
34. Blood-brain barrier: Penetration of morphine, codeine, heroin, and methadone after carotid injection
35. Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo
36. Glutathione S-transferase, cytochrome P450, and uridine 5′-diphosphateglucuronosyltransferase in human small intestine and liver
37. Influence of polarity on dose-response relationships of intrathecal opioids in rats
38. Expression and localisation of CYP2D enzymes in rat basal ganglia
39. Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain
40. Schizophrenia as a brain disease. The dopamine receptor story
41. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: Differential elevation of cyclooxygenase 2 in inflammatory joint diseases
42. Distribution and cellular localization of prostacyclin synthase in human brain
43. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease
44. Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reaction
45. Characterization of cytochrome P-450 2D1 activity in rat brain: High-affinity kinetics for dextromethorphan
46. Cytochrome P-450 activities in human and rat brain microsomes
47. Demonstration of morphine in ganglion cells of the hippocampus from victims of heroin overdose by means of antimorphine antiserum
48. Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin
49. Cytochromes P450 of the 2D subfamily in rat brain
50. An optimized method for in situ hybridization with signal amplification that allows the detection of rare mRNAs
51. Antibodies against human cytochrome P-450dbl in autoimmune hepatitis type II